PERBANDINGAN LAMA RAWAT INAP PADA PASIEN GAGAL JANTUNG DENGAN TERAPI SPIRONOLAKTON DAN FUROSEMIDE DI RSUD DR. SOEKARDJO TASIKMALAYA
Cardiovascular disease is the highest non-communicable disease in the world every year, including heart failure (HF). Tasikmalaya City government's data shows that HF is still the fourth highest inpatient disease at Dr. Soekardjo Tasikmalaya Regional General Hospital in 2020, with a total of 45...
Saved in:
| Main Author: | |
|---|---|
| Format: | Book |
| Published: |
2023-01-16.
|
| Subjects: | |
| Online Access: | Link Metadata |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | repoupnvj_22226 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Joel Owenardo Maruli Tua, . |e author |
| 245 | 0 | 0 | |a PERBANDINGAN LAMA RAWAT INAP PADA PASIEN GAGAL JANTUNG DENGAN TERAPI SPIRONOLAKTON DAN FUROSEMIDE DI RSUD DR. SOEKARDJO TASIKMALAYA |
| 260 | |c 2023-01-16. | ||
| 500 | |a http://repository.upnvj.ac.id/22226/1/ABSTRAK.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/3/AWAL.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/2/BAB%201.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/9/BAB%202.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/5/BAB%203.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/6/BAB%204.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/4/BAB%205.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/8/DAFTAR%20PUSTAKA.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/14/RIWAYAT%20HIDUP.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/12/LAMPIRAN.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/13/HASIL%20PLAGIARISME.pdf | ||
| 500 | |a http://repository.upnvj.ac.id/22226/11/ARTIKEL%20KI.pdf | ||
| 520 | |a Cardiovascular disease is the highest non-communicable disease in the world every year, including heart failure (HF). Tasikmalaya City government's data shows that HF is still the fourth highest inpatient disease at Dr. Soekardjo Tasikmalaya Regional General Hospital in 2020, with a total of 458 cases. Administration of spironolactone and furosemide are the two most frequently administered therapies for hospitalized HF patients with symptoms of congestion. This study aims to compare the length of stay of HF patients with spironolactone and furosemide therapy at Dr. Soekardjo Tasikmalaya Regional General Hospital. This is a descriptive-analytic observational study using a cohort-retrospective approach to 60 heart failure patients at Dr. Soekardjo Tasikmalaya Regional General Hospital from 2020-2021. The sampling technique used was the consecutive sampling method. Samples were divided into two groups, which consisted of 30 patients on spironolactone therapy and 30 patients on furosemide therapy. Using an unpaired t-test with the SPSS version 24.0 computer program, the results showed that the average length of stay of HF patients treated with spironolactone was 5,167 (±1,262) days. In contrast, the average length of stay of HF patients treated with furosemide was 5,9 (±1,626) days. A comparison of the average of the two groups showed a significant difference with a value of p=0.036. In conclusion, HF patients treated with spironolactone likely had a shorter average length of stay than HF patients treated with furosemide. | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 546 | |a id | ||
| 690 | |a R Medicine (General) | ||
| 690 | |a RC Internal medicine | ||
| 690 | |a RM Therapeutics. Pharmacology | ||
| 690 | |a RS Pharmacy and materia medica | ||
| 690 | |a RZ Other systems of medicine | ||
| 655 | 7 | |a Thesis |2 local | |
| 655 | 7 | |a NonPeerReviewed |2 local | |
| 787 | 0 | |n http://repository.upnvj.ac.id/22226/ | |
| 787 | 0 | |n http://repository.upnvj.ac.id | |
| 856 | 4 | 1 | |u http://repository.upnvj.ac.id/22226/ |z Link Metadata |